Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens
Status:
Not yet recruiting
Trial end date:
2023-09-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of daily and every other day
dosing of rimegepant to placebo as a preventive treatment for episodic migraine.